Cannabis Bioscience International Holdings CBIH

Cannabis Bioscience International Holdings files late 10-Q for Aug 2026

Late notice: the 10-Q will be filed late

Form
NT 10-Q
Filed
Importance
Notable
  1. Quarter ended Aug 31, 2026
  2. Clinical-trial business ended July 31, 2026
  3. Anticipated revenue of $1,000 vs $24,200 in 2025

Written from the NT 10-Q on EDGAR. Check the filing before you rely on it.

Get an email when Cannabis Bioscience International Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8731 and related industry codes: the same peer list as the financial tables.